|
EP2447370B1
(en)
|
2001-09-28 |
2018-07-18 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
MicroRNA molecules
|
|
US8137910B2
(en)
|
2002-05-03 |
2012-03-20 |
Duke University |
Method of regulating gene expression
|
|
US7892793B2
(en)
|
2002-11-04 |
2011-02-22 |
University Of Massachusetts |
Allele-specific RNA interference
|
|
CA2504605C
(en)
|
2002-11-13 |
2016-01-19 |
Thomas Jefferson University |
Treatment of chronic lymphocytic leukemia and prostate cancer with microrna mir15
|
|
WO2004058052A2
(en)
|
2002-12-20 |
2004-07-15 |
Applera Corporation |
Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
|
|
JP2006519008A
(ja)
|
2003-02-10 |
2006-08-24 |
独立行政法人産業技術総合研究所 |
哺乳動物細胞の調節
|
|
US8145436B2
(en)
|
2003-07-15 |
2012-03-27 |
The Trustees Of The University Of Pennsylvania |
Method and systems for identifying micro-RNA targets and synthesizing novel micro-RNAs and uses of the same
|
|
US7683036B2
(en)
|
2003-07-31 |
2010-03-23 |
Regulus Therapeutics Inc. |
Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
|
|
US8106180B2
(en)
|
2003-08-07 |
2012-01-31 |
Whitehead Institute For Biomedical Research |
Methods and products for expression of micro RNAs
|
|
WO2005017145A1
(ja)
|
2003-08-13 |
2005-02-24 |
Japan Biological Informatics Consortium |
機能性ｒｎａが制御する被制御遺伝子の同定・予測方法及びその利用方法
|
|
JPWO2005028648A1
(ja)
|
2003-09-22 |
2007-11-15 |
愛知県 |
リンパ腫の病型および予後診断方法
|
|
JP2007512805A
(ja)
|
2003-10-14 |
2007-05-24 |
ノバルティス アクチエンゲゼルシャフト |
オリゴヌクレオチドマイクロアレイ
|
|
JP2007511528A
(ja)
|
2003-11-13 |
2007-05-10 |
ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム |
心肥大および心不全の処置としてのｔｒｐチャネル阻害方法
|
|
US7674617B2
(en)
|
2003-12-15 |
2010-03-09 |
College of Medicine, Pochon Cha University Industry -Academic Cooperation Foundation |
MiRNA molecules isolated from human embryonic stem cell
|
|
US20050256072A1
(en)
|
2004-02-09 |
2005-11-17 |
University Of Massachusetts |
Dual functional oligonucleotides for use in repressing mutant gene expression
|
|
CA2554818A1
(en)
|
2004-02-09 |
2005-08-25 |
Thomas Jefferson University |
Diagnosis and treatment of cancers with microrna located in or near cancer-associated chromosomal features
|
|
EP1723162A4
(en)
|
2004-02-13 |
2010-05-05 |
Univ Rockefeller |
ANTI-microRNA oligonucleotide molecules
|
|
US8088902B2
(en)
|
2004-04-05 |
2012-01-03 |
The Rockefeller University |
DNA virus microRNA and methods for inhibiting same
|
|
US20060134639A1
(en)
|
2004-04-06 |
2006-06-22 |
Huffel Christophe V |
Method for the determination of cellular transcriptional regulation
|
|
US20050260648A1
(en)
|
2004-04-06 |
2005-11-24 |
Huffel Christophe V |
Method for the determination of cellular transcriptional
|
|
CA2562390C
(en)
|
2004-04-07 |
2014-12-02 |
Exiqon A/S |
Novel methods for quantification of micrornas and small interfering rnas
|
|
EP2290073A3
(en)
|
2004-05-28 |
2011-08-31 |
Asuragen, Inc. |
Methods and compositions involving microRNA
|
|
EP1791567B1
(en)
|
2004-08-10 |
2015-07-29 |
Alnylam Pharmaceuticals Inc. |
Chemically modified oligonucleotides
|
|
EP2338994B1
(en)
|
2004-09-02 |
2014-03-19 |
Yale University |
Regulation of oncogenes by microRNAs
|
|
FR2877350B1
(fr)
|
2004-11-03 |
2010-08-27 |
Centre Nat Rech Scient |
IDENTIFICATION ET UTILISATION DE miRNAs IMPLIQUES DANS LA DIFFERENCIATION DE CELLULES ISSUES D'UNE LEUCEMIE MYELOIDE
|
|
EP2302055B1
(en)
|
2004-11-12 |
2014-08-27 |
Asuragen, Inc. |
Methods and compositions involving miRNA and miRNA inhibitor molecules
|
|
WO2006063356A1
(en)
|
2004-12-10 |
2006-06-15 |
Isis Phamaceuticals, Inc. |
Regulation of epigenetic control of gene expression
|
|
US20060185027A1
(en)
|
2004-12-23 |
2006-08-17 |
David Bartel |
Systems and methods for identifying miRNA targets and for altering miRNA and target expression
|
|
US20060166920A1
(en)
|
2005-12-27 |
2006-07-27 |
Regents Of The University Of Michigan |
Oligonucleotide based therapeutics
|
|
EP1838870A2
(en)
|
2004-12-29 |
2007-10-03 |
Exiqon A/S |
NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF MICRORNAS AND THEIR TARGET MRNAs
|
|
US8071306B2
(en)
|
2005-01-25 |
2011-12-06 |
Merck Sharp & Dohme Corp. |
Methods for quantitating small RNA molecules
|
|
US20070065840A1
(en)
|
2005-03-23 |
2007-03-22 |
Irena Naguibneva |
Novel oligonucleotide compositions and probe sequences useful for detection and analysis of microRNAS and their target mRNAS
|
|
JP2006292367A
(ja)
|
2005-04-05 |
2006-10-26 |
Mitsubishi Rayon Co Ltd |
ｍｉＲＮＡ検出用マイクロアレイ
|
|
CA2604333A1
(en)
|
2005-04-15 |
2006-10-19 |
Cenix Bioscience Gmbh |
Human marker genes and agents for cardiovascular disorders and artherosclerosis
|
|
CN101203611B
(zh)
|
2005-04-19 |
2013-08-14 |
巴斯福植物科学有限公司 |
控制基因表达的改良方法
|
|
CA2609142C
(en)
|
2005-05-27 |
2016-02-09 |
Fondazione Centro San Raffaele Del Monte Tabor |
Therapeutic gene vectors comprising mirna target sequences
|
|
CA2610265A1
(en)
|
2005-05-31 |
2007-05-10 |
Cold Spring Harbor Laboratory |
Methods for producing micrornas
|
|
US20070054287A1
(en)
|
2005-05-31 |
2007-03-08 |
Applera Corporation |
Method for identifying medically important cell populations using micro rna as tissue specific biomarkers
|
|
WO2006133022A2
(en)
|
2005-06-03 |
2006-12-14 |
The Johns Hopkins University |
Compositions and methods for decreasing microrna expression for the treatment of neoplasia
|
|
US20070213292A1
(en)
|
2005-08-10 |
2007-09-13 |
The Rockefeller University |
Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
|
|
AU2006279906B2
(en)
|
2005-08-10 |
2012-05-10 |
Alnylam Pharmaceuticals, Inc. |
Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
|
|
CN101426912A
(zh)
|
2005-08-17 |
2009-05-06 |
瑟纳治疗公司 |
介导rna干扰的化学修饰短干扰核酸分子
|
|
JP2009507918A
(ja)
|
2005-09-12 |
2009-02-26 |
ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション |
Ｂｃｌ２関連癌の診断及び療法のための組成物及び方法
|
|
US20070092882A1
(en)
|
2005-10-21 |
2007-04-26 |
Hui Wang |
Analysis of microRNA
|
|
EP1951736A4
(en)
|
2005-11-21 |
2009-12-16 |
Johnson & Johnson Res Pty Ltd |
INTERFERING MULTICIBLATION RNA AND METHODS OF USE AND DESIGN
|
|
US20070259827A1
(en)
|
2006-01-25 |
2007-11-08 |
University Of Massachusetts |
Compositions and methods for enhancing discriminatory RNA interference
|
|
WO2007092181A2
(en)
|
2006-01-26 |
2007-08-16 |
Unversity Of Massachusetts |
Compositions and methods for modulating translational repression
|
|
WO2007089607A2
(en)
|
2006-01-26 |
2007-08-09 |
University Of Massachusetts |
Rna silencing agents for use in therapy and nanotransporters for efficient delivery of same
|
|
AU2007211082B2
(en)
|
2006-01-27 |
2012-09-27 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds and compositions for the use in modulation of microRNAs
|
|
WO2007095387A2
(en)
|
2006-02-17 |
2007-08-23 |
Dharmacon, Inc. |
Compositions and methods for inhibiting gene silencing by rna interference
|
|
EP2522746B1
(en)
|
2006-03-02 |
2014-11-12 |
The Ohio State University Research Foundation |
MicroRNA expression profile associated with pancreatic cancer
|
|
EP2007888A2
(en)
|
2006-04-03 |
2008-12-31 |
Santaris Pharma A/S |
Pharmaceutical composition comprising anti-mirna antisense oligonucleotides
|
|
US20080220423A1
(en)
|
2006-05-19 |
2008-09-11 |
Soren Moller |
Oligonucleotide probes useful for detection and analysis of microRNA precursors
|
|
WO2007147067A2
(en)
|
2006-06-14 |
2007-12-21 |
Rosetta Inpharmatics Llc |
Methods and compositions for regulating cell cycle progression
|
|
WO2007147409A2
(en)
|
2006-06-19 |
2007-12-27 |
Københavns Universitet |
Ribozyme mediated stabilization of polynucleotides
|
|
EP2054529B1
(en)
|
2006-08-25 |
2014-03-26 |
Duke University |
Methods for in vivo identification of endogenous mrna targets of micrornas
|
|
WO2008036776A2
(en)
|
2006-09-19 |
2008-03-27 |
Asuragen, Inc. |
Mir-15, mir-26, mir -31,mir -145, mir-147, mir-188, mir-215, mir-216 mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention
|
|
US20090306181A1
(en)
|
2006-09-29 |
2009-12-10 |
Children's Medical Center Corporation |
Compositions and methods for evaluating and treating heart failure
|
|
EP2208798B1
(de)
|
2006-10-09 |
2013-08-07 |
Medizinische Hochschule Hannover |
MicroRNA (miRNA) zur Diagnose und Therapie von Herzerkrankungen
|
|
WO2008147430A2
(en)
|
2006-10-11 |
2008-12-04 |
Nucleonics, Inc. |
Microrna-formatted multitarget interfering rna vector constructs and methods of using the same
|
|
AU2007323469B2
(en)
|
2006-11-23 |
2014-07-24 |
Guangdong Maijinjia Biotechnology Co., Ltd |
Oligonucleotides for modulating target RNA activity
|
|
AU2007333107A1
(en)
|
2006-12-08 |
2008-06-19 |
Asuragen, Inc. |
miR-21 regulated genes and pathways as targets for therapeutic intervention
|
|
AU2007333109A1
(en)
|
2006-12-08 |
2008-06-19 |
Asuragen, Inc. |
Functions and targets of let-7 micro RNAs
|
|
EP2104736B1
(en)
|
2006-12-08 |
2011-11-23 |
Asuragen, INC. |
Mir-126 regulated genes and pathways as targets for therapeutic intervention
|
|
EP2102341A2
(en)
|
2006-12-08 |
2009-09-23 |
Asuragen, INC. |
Mirna regulated genes and pathways as targets for therapeutic intervention
|
|
EP3536788A1
(en)
|
2006-12-21 |
2019-09-11 |
QIAGEN GmbH |
Microrna target site blocking oligos and uses thereof
|
|
WO2008074328A2
(en)
|
2006-12-21 |
2008-06-26 |
Exiqon A/S |
Microrna target site blocking oligos and uses thereof
|
|
CA2671270A1
(en)
|
2006-12-29 |
2008-07-17 |
Asuragen, Inc. |
Mir-16 regulated genes and pathways as targets for therapeutic intervention
|
|
US20080287383A1
(en)
|
2007-03-02 |
2008-11-20 |
Nastech Pharmaceutical Company Inc. |
Nucleic acid compounds for inhibiting erbb gene expression and uses thereof
|
|
WO2008112226A2
(en)
|
2007-03-13 |
2008-09-18 |
Massachusetts Institute Of Technology |
Cre-lox based gene knockdown constructs and methods of use thereof
|
|
US8288358B2
(en)
|
2007-03-26 |
2012-10-16 |
Newcastle Innovation Ltd. |
Therapeutic targets and molecules
|
|
WO2008147837A1
(en)
|
2007-05-23 |
2008-12-04 |
Dharmacon, Inc. |
Micro-rna scaffolds, non-naturally occurring micro-rnas, and methods for optimizing non-naturally occurring micro-rnas
|
|
CA2693031A1
(en)
|
2007-07-18 |
2009-01-22 |
The Regents Of The University Colorado |
Differential expression of micrornas in nonfailing versus failing human hearts
|
|
WO2009012263A2
(en)
|
2007-07-18 |
2009-01-22 |
The Trustees Of Columbia University In The City Of New York |
Tissue-specific micrornas and compositions and uses thereof
|
|
US20090092980A1
(en)
|
2007-07-20 |
2009-04-09 |
Christoph Arenz |
miRNA PROCESSING INHIBITOR EFFICACY ASSAYS AND SUBSTANCES
|
|
WO2009044895A1
(ja)
|
2007-10-03 |
2009-04-09 |
Kyowa Hakko Kirin Co., Ltd. |
標的遺伝子の発現を抑制する組成物
|
|
EP2623599B1
(en)
|
2007-10-04 |
2019-01-02 |
Roche Innovation Center Copenhagen A/S |
Micromirs
|
|
EP2222283A2
(en)
|
2007-10-29 |
2010-09-01 |
University of Massachusetts |
Yeast cell wall protein (ycwp) encapsulated multilayered nanoparticles for nucleic acid delivery (sirna)
|
|
WO2009058818A2
(en)
|
2007-10-29 |
2009-05-07 |
The Board Of Regents Of The University Of Texas System |
Compositions comprising a micro-rna and methods of their use in regulating cardiac remodeling
|
|
KR20100099158A
(ko)
|
2007-11-09 |
2010-09-10 |
보드 오브 리전츠 더 유니버시티 오브 텍사스 시스템 |
심근세포 생존과 심장 회복을 제어하는 ＭＩＲ-15 집단의 마이크로ＲＮＡｓ
|
|
WO2009066967A2
(en)
*
|
2007-11-23 |
2009-05-28 |
Panagene Inc. |
Microrna antisense pnas, compositions comprising the same, and methods for using and evaluating the same
|
|
CA2717792A1
(en)
|
2008-03-07 |
2009-09-11 |
Santaris Pharma A/S |
Pharmaceutical compositions for treatment of microrna related diseases
|
|
WO2009121031A1
(en)
|
2008-03-27 |
2009-10-01 |
Vascular Biosciences, Inc. |
Methods of novel therapeutic candidate identification through gene expression analysis in vascular-related diseases
|
|
EP2105145A1
(en)
|
2008-03-27 |
2009-09-30 |
ETH Zürich |
Method for muscle-specific delivery lipid-conjugated oligonucleotides
|
|
US20090326049A1
(en)
|
2008-04-04 |
2009-12-31 |
Alexander Aristarkhov |
Blocking oligos for inhibition of microrna and sirna activity and uses thereof
|
|
US20100113284A1
(en)
|
2008-04-04 |
2010-05-06 |
Alexander Aristarkhov |
Small interfering rna (sirna) target site blocking oligos and uses thereof
|
|
WO2009137807A2
(en)
|
2008-05-08 |
2009-11-12 |
Asuragen, Inc. |
Compositions and methods related to mirna modulation of neovascularization or angiogenesis
|
|
US8222221B2
(en)
|
2008-06-04 |
2012-07-17 |
The Board Of Regents Of The University Of Texas System |
Modulation of gene expression through endogenous small RNA targeting of gene promoters
|
|
WO2010036939A2
(en)
|
2008-09-26 |
2010-04-01 |
University Of Southern California |
A system for synergistic expression of multiple small functional rna elements
|
|
EP2447274B1
(en)
|
2008-10-24 |
2017-10-04 |
Ionis Pharmaceuticals, Inc. |
Oligomeric compounds and methods
|
|
WO2010126355A1
(en)
|
2009-04-29 |
2010-11-04 |
Academisch Medisch Centrum Bij De Universiteit Van Amsterdam |
Means and methods for counteracting, preventing and/or determining heart failure, or a risk of heart failure
|
|
SG176716A1
(en)
|
2009-06-08 |
2012-01-30 |
Miragen Therapeutics |
CHEMICAL MODIFICATION MOTIFS FOR miRNA INHIBITORS AND MIMETICS
|